Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Striatal Interneurons in Transgenic Nonhuman Primate Model of Huntington's Disease.

Lallani SB, Villalba RM, Chen Y, Smith Y, Chan AWS.

Sci Rep. 2019 Mar 5;9(1):3528. doi: 10.1038/s41598-019-40165-w.

2.

Reduced striatal acetylcholine efflux in the R6/2 mouse model of Huntington's disease: an examination of the role of altered inhibitory and excitatory mechanisms.

Farrar AM, Callahan JW, Abercrombie ED.

Exp Neurol. 2011 Dec;232(2):119-25. doi: 10.1016/j.expneurol.2011.08.010. Epub 2011 Aug 16.

PMID:
21864528
3.

Towards a transgenic model of Huntington's disease in a non-human primate.

Yang SH, Cheng PH, Banta H, Piotrowska-Nitsche K, Yang JJ, Cheng EC, Snyder B, Larkin K, Liu J, Orkin J, Fang ZH, Smith Y, Bachevalier J, Zola SM, Li SH, Li XJ, Chan AW.

Nature. 2008 Jun 12;453(7197):921-4. doi: 10.1038/nature06975. Epub 2008 May 18.

4.

A two years longitudinal study of a transgenic Huntington disease monkey.

Chan AW, Xu Y, Jiang J, Rahim T, Zhao D, Kocerha J, Chi T, Moran S, Engelhardt H, Larkin K, Neumann A, Cheng H, Li C, Nelson K, Banta H, Zola SM, Villinger F, Yang J, Testa CM, Mao H, Zhang X, Bachevalier J.

BMC Neurosci. 2014 Mar 3;15:36. doi: 10.1186/1471-2202-15-36.

5.

Striatal Vulnerability in Huntington's Disease: Neuroprotection Versus Neurotoxicity.

Morigaki R, Goto S.

Brain Sci. 2017 Jun 7;7(6). pii: E63. doi: 10.3390/brainsci7060063. Review.

6.

Disrupted striatal neuron inputs and outputs in Huntington's disease.

Reiner A, Deng YP.

CNS Neurosci Ther. 2018 Apr;24(4):250-280. doi: 10.1111/cns.12844. Review.

PMID:
29582587
7.

Loss-of-Huntingtin in Medial and Lateral Ganglionic Lineages Differentially Disrupts Regional Interneuron and Projection Neuron Subtypes and Promotes Huntington's Disease-Associated Behavioral, Cellular, and Pathological Hallmarks.

Mehler MF, Petronglo JR, Arteaga-Bracho EE, Gulinello ME, Winchester ML, Pichamoorthy N, Young SK, DeJesus CD, Ishtiaq H, Gokhan S, Molero AE.

J Neurosci. 2019 Mar 6;39(10):1892-1909. doi: 10.1523/JNEUROSCI.2443-18.2018. Epub 2019 Jan 9.

PMID:
30626701
8.

Huntingtin immunoreactivity in the rat neostriatum: differential accumulation in projection and interneurons.

Kosinski CM, Cha JH, Young AB, Persichetti F, MacDonald M, Gusella JF, Penney JB Jr, Standaert DG.

Exp Neurol. 1997 Apr;144(2):239-47.

PMID:
9168825
9.

Striatal parvalbuminergic neurons are lost in Huntington's disease: implications for dystonia.

Reiner A, Shelby E, Wang H, Demarch Z, Deng Y, Guley NH, Hogg V, Roxburgh R, Tippett LJ, Waldvogel HJ, Faull RL.

Mov Disord. 2013 Oct;28(12):1691-9. doi: 10.1002/mds.25624. Epub 2013 Sep 3.

10.

Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.

Wegrzynowicz M, Bichell TJ, Soares BD, Loth MK, McGlothan JS, Mori S, Alikhan FS, Hua K, Coughlin JM, Holt HK, Jetter CS, Pomper MG, Osmand AP, Guilarte TR, Bowman AB.

J Huntingtons Dis. 2015;4(1):17-36.

11.

Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons.

Picconi B, Passino E, Sgobio C, Bonsi P, Barone I, Ghiglieri V, Pisani A, Bernardi G, Ammassari-Teule M, Calabresi P.

Neurobiol Dis. 2006 Apr;22(1):143-52. Epub 2005 Dec 2.

PMID:
16326108
12.

[Huntington disease. A review].

Bonilla E.

Invest Clin. 2000 Jun;41(2):117-41. Review. Spanish.

PMID:
10961047
13.

Transient global ischemia in rats yields striatal projection neuron and interneuron loss resembling that in Huntington's disease.

Meade CA, Figueredo-Cardenas G, Fusco F, Nowak TS Jr, Pulsinelli WA, Reiner A.

Exp Neurol. 2000 Dec;166(2):307-23.

PMID:
11085896
14.

Cellular therapy and induced neuronal replacement for Huntington's disease.

Benraiss A, Goldman SA.

Neurotherapeutics. 2011 Oct;8(4):577-90. doi: 10.1007/s13311-011-0075-8. Review.

15.

Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.

Reddy PH, Charles V, Williams M, Miller G, Whetsell WO Jr, Tagle DA.

Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1035-45.

17.

Striatal atrophy and dendritic alterations in a knock-in mouse model of Huntington's disease.

Lerner RP, Trejo Martinez Ldel C, Zhu C, Chesselet MF, Hickey MA.

Brain Res Bull. 2012 Apr 10;87(6):571-8. doi: 10.1016/j.brainresbull.2012.01.012. Epub 2012 Feb 4.

18.
19.

Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington's disease.

Fusco FR, Chen Q, Lamoreaux WJ, Figueredo-Cardenas G, Jiao Y, Coffman JA, Surmeier DJ, Honig MG, Carlock LR, Reiner A.

J Neurosci. 1999 Feb 15;19(4):1189-202.

20.

Changes in striatal activity and functional connectivity in a mouse model of Huntington's disease.

Cabanas M, Bassil F, Mons N, Garret M, Cho YH.

PLoS One. 2017 Sep 21;12(9):e0184580. doi: 10.1371/journal.pone.0184580. eCollection 2017.

Supplemental Content

Support Center